Stay updated on HPN217 in R/R MM: Safety, PK, Clinical Trial
Sign up to get notified when there's something new on the HPN217 in R/R MM: Safety, PK, Clinical Trial page.

Latest updates to the HPN217 in R/R MM: Safety, PK, Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check34 days agoNo Change Detected
- Check41 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check48 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
- Check62 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
- Check70 days agoChange DetectedThe website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in its functionality.SummaryDifference0.2%
- Check91 days agoChange DetectedNew study details for HPN217 in relapsed/refractory multiple myeloma have been added, including updated dates and additional study numbers, while previous entries have been removed.SummaryDifference0.6%
Stay in the know with updates to HPN217 in R/R MM: Safety, PK, Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HPN217 in R/R MM: Safety, PK, Clinical Trial page.